PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
November 19, 2026 2.821
November 18, 2026 2.821
November 17, 2026 2.821
November 16, 2026 2.821
November 13, 2026 2.821
November 12, 2026 2.821
November 11, 2026 2.821
November 10, 2026 2.821
November 09, 2026 2.821
November 06, 2026 2.821
November 05, 2026 2.640
November 04, 2026 2.640
November 03, 2026 2.640
November 02, 2026 2.640
October 30, 2026 2.640
October 29, 2026 2.640
October 28, 2026 2.640
October 27, 2026 2.640
October 26, 2026 3.574
October 23, 2026 3.574
October 22, 2026 3.574
October 21, 2026 3.574
October 20, 2026 3.574
October 19, 2026 3.574
October 16, 2026 3.574
Date Value
October 15, 2026 3.574
October 14, 2026 3.574
October 13, 2026 3.574
October 12, 2026 3.574
October 09, 2026 3.574
October 08, 2026 3.574
October 07, 2026 3.574
October 06, 2026 3.574
October 05, 2026 3.574
October 02, 2026 3.574
October 01, 2026 3.574
September 30, 2026 3.574
September 29, 2026 3.574
September 28, 2026 3.574
September 25, 2026 3.574
September 24, 2026 3.574
September 23, 2026 3.574
September 22, 2026 3.181
September 21, 2026 3.181
September 18, 2026 3.181
September 17, 2026 3.351
September 16, 2026 3.430
September 15, 2026 3.430
September 14, 2026 3.430
September 11, 2026 3.430

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Nicox SA 1.269
DBV Technologies SA --
Cellectis SA 1.758
Genfit SA 7.617
Innate Pharma SA 17.86

PS Ratio Related Metrics

PEG Ratio -0.0189
Price to Book Value 5.439
Price 2.66
Earnings Yield -39.35%
Market Cap 504.46M
PEGY Ratio -0.0189